These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 31336983)

  • 61. Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer.
    Cruz da Silva E; Dontenwill M; Choulier L; Lehmann M
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31109009
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen.
    Meerovitch K; Bergeron F; Leblond L; Grouix B; Poirier C; Bubenik M; Chan L; Gourdeau H; Bowlin T; Attardo G
    Vascul Pharmacol; 2003 Feb; 40(2):77-89. PubMed ID: 12646396
    [TBL] [Abstract][Full Text] [Related]  

  • 63. αv integrin processing interferes with the cross-talk between αvβ5/β6 and α2β1 integrins.
    Defilles C; Montero MP; Lissitzky JC; Rome S; Siret C; Luis J; André F; Rigot V
    Biol Cell; 2011 Nov; 103(11):519-29. PubMed ID: 21787362
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inside the Cell: Integrins as New Governors of Nuclear Alterations?
    Madrazo E; Conde AC; Redondo-Muñoz J
    Cancers (Basel); 2017 Jul; 9(7):. PubMed ID: 28684679
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Integrin Regulation of CAF Differentiation and Function.
    DiPersio CM; Van De Water L
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31137641
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of integrin drug targets for 17 solid tumor types.
    Arun AS; Tepper CG; Lam KS
    Oncotarget; 2018 Jul; 9(53):30146-30162. PubMed ID: 30046394
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MicroRNAs Can Influence Ovarian Cancer Progression by Dysregulating Integrin Activity.
    Fasoulakis Z; Psarommati MZ; Papapanagiotou A; Pergialiotis V; Koutras A; Douligeris A; Mortaki A; Mihail A; Theodora M; Stavros S; Karakalpakis D; Papamihail M; Kontomanolis EN; Daskalakis G; Antsaklis P
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760437
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Biological Functions and Clinical Applications of Integrins in Cancers.
    Su CY; Li JQ; Zhang LL; Wang H; Wang FH; Tao YW; Wang YQ; Guo QR; Li JJ; Liu Y; Yan YY; Zhang JY
    Front Pharmacol; 2020; 11():579068. PubMed ID: 33041823
    [TBL] [Abstract][Full Text] [Related]  

  • 69. β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer.
    Blandin AF; Renner G; Lehmann M; Lelong-Rebel I; Martin S; Dontenwill M
    Front Pharmacol; 2015; 6():279. PubMed ID: 26635609
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation.
    Niland S; Eble JA
    J Oncol; 2012; 2012():125278. PubMed ID: 21941547
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Role of Integrins for Mediating Nanodrugs to Improve Performance in Tumor Diagnosis and Treatment.
    Yu C; Jiang W; Li B; Hu Y; Liu D
    Nanomaterials (Basel); 2023 May; 13(11):. PubMed ID: 37299624
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.
    Lu X; Lu D; Scully M; Kakkar V
    Perspect Medicin Chem; 2008 Apr; 2():57-73. PubMed ID: 19787098
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Integrin inhibitors as a therapeutic agent for ovarian cancer.
    Sawada K; Ohyagi-Hara C; Kimura T; Morishige K
    J Oncol; 2012; 2012():915140. PubMed ID: 22235205
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Integrins as Therapeutic Targets: Successes and Cancers.
    Raab-Westphal S; Marshall JF; Goodman SL
    Cancers (Basel); 2017 Aug; 9(9):. PubMed ID: 28832494
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Back to basic: Trials and tribulations of alkalizing agents in cancer.
    Gillies RJ; Ibrahim-Hashim A; Ordway B; Gatenby RA
    Front Oncol; 2022; 12():981718. PubMed ID: 36452492
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Integrins are double-edged swords in pulmonary infectious diseases.
    Yao Y; Liu H; Yuan L; Du X; Yang Y; Zhou K; Wu X; Qin L; Yang M; Xiang Y; Qu X; Qin X; Liu C
    Biomed Pharmacother; 2022 Sep; 153():113300. PubMed ID: 35728353
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting the tumor-stromal-immune cell axis.
    Gururajan M; Josson S; Chung LW
    Oncoscience; 2015; 2(9):743-4. PubMed ID: 26501076
    [No Abstract]   [Full Text] [Related]  

  • 78. Editorial: Women in molecular and cellular oncology, volume II: 2022.
    Dhar SS
    Front Oncol; 2023; 13():1272365. PubMed ID: 37727215
    [No Abstract]   [Full Text] [Related]  

  • 79. The Roles of Integrin α5β1 in Human Cancer.
    Hou J; Yan D; Liu Y; Huang P; Cui H
    Onco Targets Ther; 2020; 13():13329-13344. PubMed ID: 33408483
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Integrin α3β1 Promotes Invasive and Metastatic Properties of Breast Cancer Cells through Induction of the Brn-2 Transcription Factor.
    Miskin RP; Warren JSA; Ndoye A; Wu L; Lamar JM; DiPersio CM
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.